Aethir: Fully supports the technological innovation of AI Agent, possessing the necessary capabilities to support large-scale AI agent development
On December 5th, decentralized cloud infrastructure provider Aethir announced that the number of artificial intelligence companies developing AI agent variants for different industries is growing exponentially. Aethir possesses the necessary decentralized infrastructure to accommodate this growth. For instance, Aethir recently launched a $100 million ecosystem fund aimed at supporting AI builders in launching innovative projects such as AI agents across various industries. So far, Aethir has announced two rounds of projects funded by its ecosystem fund.
Aethir's decentralized GPU provides scalable cloud computing services capable of supporting the advanced AI workloads required for successful training of AI agents. With over 43,000 top-tier GPUs and more than 3,000 NVIDIA h100s, it can support the most complex LLM training, machine learning workloads and AI agent projects. In addition to this, Aethir has distributed over 32,000 Aethir Edge decentralized GPU cloud computing devices to users worldwide.
Aethir's decentralized cloud infrastructure is supported by more than 91,000 inspection nodes responsible for ensuring optimal service quality for all GPU containers on its network. Through the New Horizons program, Aethir is adding new decentralized GPU cloud hosts to enhance its ability to provide GPU computation for AI agents - an essential capability that enables large-scale development of AI agents.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Variational open interest has exceeded $2 billions.
Janus Henderson Macro Head Says Market Is Near Its Top but Cannot Say When
A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.
Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.
Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request
A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.